Pulmonary function tests (PFTs) are critical tools in diagnosing and managing respiratory conditions. However, accurate interpretation requires a comprehensive understanding of the tests' intricacies.
Spirometry measures airway obstruction by assessing Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1). A reduced FEV1/FVC ratio indicates obstructive disease.
Total Lung Capacity (TLC), Residual Volume (RV) and Functional Residual Capacity (FRC) are crucial in identifying restrictive diseases. Increased RV and FRC suggest air trapping, typical in obstructive disorders.
Diffusing capacity of the lungs for carbon monoxide (DLCO) assesses gas exchange efficiency. A reduced DLCO may indicate interstitial lung disease or pulmonary vascular disease.
Interpreting PFTs is complex, requiring a thorough understanding of respiratory physiology and pathology. By mastering these concepts, healthcare professionals can effectively diagnose and manage respiratory conditions.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation